The complete monitoring panel — which tests matter, what numbers signal a problem, and how often to check.
When you stop a GLP-1 medication, your metabolic markers begin shifting within weeks — often before you feel anything or see the scale move. The only way to know what's happening is blood work. But most people don't know which tests to order, what numbers constitute a problem, or when to get tested.
This guide answers all three questions.
Request this exact combination from your doctor or lab: Comprehensive Metabolic Panel (CMP) + Lipid Panel + HbA1c + Fasting Insulin
This covers everything you need in a single fasting blood draw. Most labs process this within 1-3 days. Cost without insurance: approximately $50-120 at a direct-pay lab like Walk-In Lab or LabCorp Patient pricing.
HbA1c shows your average blood glucose over the past 2-3 months. On GLP-1 medications, HbA1c typically improves. After stopping, it begins reversing. The danger is that HbA1c has a 90-day lag — by the time it shows a significant rise, the underlying glucose problem has been developing for months.
Normal: Below 5.7% | Pre-diabetes: 5.7-6.4% | Diabetes: 6.5%+
Fasting insulin is the most sensitive early warning marker for post-GLP-1 metabolic rebound. GLP-1 medications improve insulin sensitivity; when they stop, insulin resistance begins returning. The SURMOUNT-4 post-hoc analysis found fasting insulin rose approximately 26.3% in patients who regained significant weight — often detectable before HbA1c or fasting glucose showed major changes.
Optimal fasting insulin: Below 8 μIU/mL | Concerning: Above 15 μIU/mL
Fasting glucose is included in the standard CMP. It reflects your glucose level after an overnight fast. After stopping GLP-1 medications, fasting glucose typically begins rising within 4-8 weeks as insulin resistance returns and the glucose-lowering effect of the medication fades.
Normal: Below 100 mg/dL | Pre-diabetes: 100-125 mg/dL | Diabetes: 126+ mg/dL
Triglycerides often improve significantly on GLP-1 therapy. After cessation, they begin rising as insulin resistance returns and dietary patterns shift. Elevated triglycerides (above 150 mg/dL) in combination with other markers indicate the insulin resistance triad — a key cliff signal pattern.
Normal: Below 150 mg/dL | Borderline: 150-199 mg/dL | High: 200+ mg/dL
LDL typically improves on GLP-1 medications as a downstream effect of weight loss and metabolic improvement. After stopping, LDL may rise, particularly if weight is regaining. For people who had elevated LDL pre-medication, monitoring is important.
HDL improvement is one of the positive effects of GLP-1 therapy. A falling HDL after cessation, combined with rising triglycerides, is a classic metabolic syndrome pattern worth monitoring.
| Marker | Why It Matters Post-Cessation | When to Order |
|---|---|---|
| Vitamin D (25-OH) | Often deficient in obesity; affects insulin signaling and immune function | First draw after stopping |
| Ferritin (iron stores) | Hair loss after GLP-1 cessation is often linked to low ferritin | If experiencing hair loss |
| TSH (thyroid) | Thyroid disorders can mimic or worsen post-cessation metabolic changes | If fatigue or unexpected weight changes |
| hsCRP (inflammation) | Inflammatory marker that worsens with metabolic deterioration | Quarterly if elevated on first draw |
| Uric acid | Can rise with weight regain and metabolic stress | If previous gout or elevated levels |
Individual markers matter, but pattern recognition matters more. Three patterns are particularly significant:
Pattern 1: Insulin Resistance Triad — HbA1c rising + fasting glucose rising + triglycerides rising together. This combination indicates progressive insulin resistance return and is the classic GLP-1 cliff pattern.
Pattern 2: Early Warning — Fasting Insulin Rising Alone — Fasting insulin begins rising while glucose and HbA1c still look normal. This is the earliest detectable cliff signal, typically appearing 4-8 weeks post-cessation. Act here and you catch the problem before other markers deteriorate.
Pattern 3: Cardiovascular Cluster — LDL rising + HDL falling + triglycerides rising. Often accompanies weight regain and indicates worsening cardiometabolic health even if glucose markers are still stable.
You don't need a physician visit to order most of these tests. Direct-to-consumer lab options include:
A full post-cessation panel (CMP + lipids + HbA1c + fasting insulin) typically costs $60-140 direct-pay, compared to $400-800 billed through insurance.
Curabook PHI analyzes your lab PDF automatically, compares to your previous values, and flags HbA1c drift, glucose rises, and insulin resistance patterns — before weight regain starts.
Upload My Labs Free →This content is for health education. Reference ranges and cliff signal thresholds are based on published clinical literature including SURMOUNT-4 post-hoc analysis (Horn et al., JAMA Internal Medicine, 2025). Individual thresholds vary — consult your healthcare provider to interpret your specific results.